EQS — News: Lenire Now Included in U.S. ENT Clinical Practice Guidelines — First New Treatment Added by American Academy of Otolaryngology Since Establishment of the Academy's Tinnitus Guidelines

EQS-News: Neuromod Devices / Key word(s): Miscellaneous/Miscellaneous Lenire Now Included in U.S. ENT Clinical Practice Guidelines — First New Treatment Added by American Academy of Otolaryngology Since Establishment of the Academy's Tinnitus Guidelines 16.10.2026 / 15:45 CET/CEST The issuer is solely responsible for the content of this announcement. ═══════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════ • The American Academy of Otolaryngology — Head and Neck Surgery Foundation has included Lenire (bimodal neuromodulation) as a treatment option for the first time in their Clinical Practice Guidelines for Tinnitus. • Lenire is the only new treatment recommendation added to the guidelines since its establishment in 2014. • Lenire, by Neuromod Devices, is the first and only FDA-approved bimodal neuromodulation tinnitus treatment device. DUBLIN, Oct. 16, 2026 // — The American Academy of Otolaryngology — Head and Neck Surgery Foundation (AAO-HNSF) has included Lenire (bimodal neuromodulation